These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7865993)

  • 1. The interaction of gadolinium complexes with isolated rat hepatocytes.
    Thorstensen K; Romslo I
    Biometals; 1995 Jan; 8(1):65-9. PubMed ID: 7865993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivo.
    Franano FN; Edwards WB; Welch MJ; Brechbiel MW; Gansow OA; Duncan JR
    Magn Reson Imaging; 1995; 13(2):201-14. PubMed ID: 7739361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the biodistribution of 153Gd-labeled Gd(DTPA)2-, Gd(DOTA)-, and Gd(acetate)n in mice.
    Wedeking P; Tweedle M
    Int J Rad Appl Instrum B; 1988; 15(4):395-402. PubMed ID: 3255735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary excretion and pharmacokinetics of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging in the rat.
    Schuhmann-Giampieri G; Schmitt-Willich H; Frenzel T; Schitt-Willich H [corrected to Schmitt-Willich H]
    J Pharm Sci; 1993 Aug; 82(8):799-803. PubMed ID: 8377117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
    Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging increases the blood-brain barrier permeability to 153-gadolinium diethylenetriaminepentaacetic acid in rats.
    Prato FS; Frappier JR; Shivers RR; Kavaliers M; Zabel P; Drost D; Lee TY
    Brain Res; 1990 Jul; 523(2):301-4. PubMed ID: 2400915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of gadolinium DTPA and gadolinium chloride.
    Dean PB; Niemi P; Kivisaari L; Kormano M
    Invest Radiol; 1988 Sep; 23 Suppl 1():S258-60. PubMed ID: 3198357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium cryptelates as MR contrast agents.
    Knop RH; Frank JA; Dwyer AJ; Girton ME; Naegele M; Schrader M; Cobb J; Gansow O; Maegerstadt M; Brechbiel M
    J Comput Assist Tomogr; 1987; 11(1):35-42. PubMed ID: 3805426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of dechelation of gadopentetate dimeglumine in rats.
    Kasokat T; Urich K
    Arzneimittelforschung; 1992 Jun; 42(6):869-76. PubMed ID: 1418049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the biodistribution of manganese-54 DTPA and gadolinium-153 DTPA in dogs.
    Boudreau RJ; Burbidge S; Sirr S; Loken MK
    J Nucl Med; 1987 Mar; 28(3):349-53. PubMed ID: 3819851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed magnetic resonance hepatic imaging with gadolinium-DTPA.
    Nelson RC; Umpierrez ME; Chezmar JL; Bernardino ME
    Invest Radiol; 1988 Jul; 23(7):509-11. PubMed ID: 3170138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs.
    Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H; Weinmann HJ
    Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of gadolinium dissociation from protein-DTPA-gadolinium complexes.
    Duncan JR; Franano FN; Edwards WB; Welch MJ
    Invest Radiol; 1994 Jun; 29 Suppl 2():S58-61. PubMed ID: 7928272
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the biodistribution of gadolinium-153 DTPA and technetium-99m DTPA in rats.
    Prato FS; Wisenberg G; Marshall TP; Uksik P; Zabel P
    J Nucl Med; 1988 Oct; 29(10):1683-7. PubMed ID: 3049959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
    Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of two new gadolinium chelates as contrast agents for MRI.
    Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE
    Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration of gadolinium-diethylene triamine pentaacetic acid in human kidney--study on proper time for dynamic magnetic resonance imaging of the human kidney on low and high magnetic fields.
    Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T; Tanikawa T; Sato S
    Tohoku J Exp Med; 1993 Oct; 171(2):119-28. PubMed ID: 8128480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and magnetic resonance imaging of Gd-EOB-DTPA in dogs.
    Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H
    Invest Radiol; 1994 Jun; 29 Suppl 2():S177-8. PubMed ID: 7928221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.